Cargando…

PEG interferon-α-2b/ribavirin: Interstitial pneumonitis and adult respiratory distress syndrome: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149234/ http://dx.doi.org/10.2165/00128415-200309680-00036

Ejemplares similares

Case Report: Severe Interstitial Pneumonitis Secondary to Pegylated Interferon α-2b and Ribavirin Treatment of Hepatitis C Infection
por: Fuhrmann, Valentin, et al.
Publicado: (2004)

Pneumonitis as A Consequence of (Peg)Interferon-Ribavirin Combination Therapy for Hepatitis C: a Review of the Literature
por: Slavenburg, Serena, et al.
Publicado: (2009)

Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report
por: Atug, Ozlen, et al.
Publicado: (2009)

Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
por: Hlaing, Naomi Khaing Than, et al.
Publicado: (2016)

The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C
por: Behnava, Bita, et al.
Publicado: (2016)

Hyperleucocytosis as an unusual presentation of hypereosinophilic pneumonitis with acute respiratory distress syndrome
por: Alshehri, Saleh Saad, et al.
Publicado: (2022)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
por: Chopra, Amit, et al.
Publicado: (2015)

Efficacy of Interferon α-2b and Ribavirin against West Nile Virus In Vitro
por: Anderson, John F., et al.
Publicado: (2002)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
por: Akram, Madiha, et al.
Publicado: (2011)

Nivolumab: Interstitial pneumonitis: case report
Publicado: (2020)

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial
por: Poulakou, Garyfallia, et al.
Publicado: (2022)

Assessment of Viral Genotype Impact to the Cost-Effectiveness and Overall Costs of Care for Peg-Interferon-2α + Ribavirine Treated Chronic Hepatitis C Patients
por: Jakovljevic, Mihajlo, et al.
Publicado: (2013)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Grubczak, Kamil, et al.
Publicado: (2021)

Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
por: Sandoughdaran, Saleh, et al.
Publicado: (2015)

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2014)

Peg-interferon Plus Ribavirin Combination Therapy in HCV Mono-infected and HCV/HIV Co-infected Patients in Iran
por: Hesamizadeh, Khashayar, et al.
Publicado: (2019)

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
por: Falzarano, Darryl, et al.
Publicado: (2013)

Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population
por: Jin, Young-Joo, et al.
Publicado: (2013)

Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia
por: Sato, Akira, et al.
Publicado: (2014)

Pembrolizumab: Interstitial bilateral pneumonitis: case report
Publicado: (2021)

Tozinameran: Interstitial pneumonitis: 3 case reports
Publicado: (2022)

Treatment of acute hepatitis C virus infection with interferon-α 2b and ribavirin: Case report and review of the literature
por: Leblebicioglu, Hakan, et al.
Publicado: (2002)

Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
por: Coppola, Nicola, et al.
Publicado: (2014)

Docetaxel-related interstitial pneumonitis
por: Wang, Chung-Jen, et al.
Publicado: (2015)

Bucillamine‐induced interstitial pneumonitis
por: Nakamoto, Keitaro, et al.
Publicado: (2018)

Trastuzumab-Induced Interstitial Pneumonitis
por: Errisuriz, Kimberly, et al.
Publicado: (2023)

Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b
por: Son, Hyoshin, et al.
Publicado: (2021)

Cutaneous side effects of combination therapy of pegylated interferon 2α and ribavirin
por: Raducan, Anca, et al.
Publicado: (2014)

Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature
por: Cacopardo, Bruno, et al.
Publicado: (2013)

Treatment with sivelestat sodium of acute respiratory distress syndrome induced by chemical pneumonitis: A report of three cases
por: Jing, Liang, et al.
Publicado: (2023)

Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin
por: Fujino, Tatsuya, et al.
Publicado: (2011)

Desvenlafaxine-Induced Interstitial Pneumonitis: A Case Report
por: Flora, Arjan, et al.
Publicado: (2018)

Osimertinib: Pneumonitis and interstitial lung disease: case report
Publicado: (2022)

Case report: Interstitial pneumonitis after initiation of lamotrigine
por: Watzal, Victoria, et al.
Publicado: (2023)

Infliximab-Induced Interstitial Pneumonitis: A Case Report
por: Makkawy, Eyad A, et al.
Publicado: (2023)

Suppression of ribosomal protein synthesis and protein translation factors by Peg-interferon alpha/ribavirin in HCV patients blood mononuclear cells (PBMC)
por: Gupta, Rahul, et al.
Publicado: (2012)

Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study
por: Arabi, Yaseen M, et al.
Publicado: (2020)

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013)

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
por: Falzarano, Darryl, et al.
Publicado: (2013)

Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
por: Pennisi, Manuela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pn4q79a61cup09t16n8pavc3r7